• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

  • About
    • General Information
    • Disease Research
    • Training & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti Aging Study
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Osteoarthritis
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Ways to Give
    • Tax Credit
    • Planned Giving
    • Contact Philanthropy
Home - OMRF News - Archives for brain cancer

brain cancer

Beating The Odds

Brain cancer survivor Mike Schuster celebrates a milestone he never thought possible.

FDA grants designations for OMRF brain tumor drug

September 2, 2020

The Oklahoma Medical Research Foundation is one step closer to beating rare forms of brain cancers.

Filed Under: Videos Tagged With: brain cancer, drug, FDA, kfor, OKN-007, Rheal, scientist-news, Towner

OMRF brain tumor drug receives rare disease designations from the FDA

September 2, 2020

The drug treats fast-growing, deadly brain cancers with no effective treatment.

Filed Under: News, Technology Ventures News Tagged With: 007, administration, approval, bob, Bob Floyd, brain cancer, cancer, center, childhood, diffuse intrinsic pontine glioma, dipg, drug, FDA, Floyd, glioblastoma, glioma, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OKN007, OMRF, OUHSC, pediatric, rare pediatric disease designation, Rheal, robert, rpdd, scientist-news, stephenson, Towner

New use for OMRF brain cancer treatment could extend lives

December 18, 2019

In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.

Filed Under: News, Technology Ventures News Tagged With: battiste, brain cancer, cancer, center, chemo, drug, glioblastoma, James, Manu Nair, newsok, OKC, Oklahoma Medical Research Foundation, OKN-007, OMRF, ou, OUHSC, patient, Rheal, scientist-news, stephenson, technology ventures, temodar, therapy, Towner, treatment, university of oklahoma

OMRF discovers compound that could fight deadly cancer

January 21, 2019

Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.

Filed Under: News Tagged With: biomedical, brain, brain cancer, cancer, compound, cure, developed, drug, eltd1, glioblastoma, john mccain, medicine, news, newsok, nonprofit, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, pharma, Rheal, rheal towner, scientist-news, ted kennedy, Towner, treat, treatment

Staying alive: Can an experimental OMRF drug stop Mike Schuster’s brain cancer?

September 11, 2018

As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.

Filed Under: News, Technology Ventures News Tagged With: aggressive, battiste, brain, brain cancer, cancer, deadly, death, develop, disease, drug, glioblastoma, john mccain, life expectancy, live, longer, mike schuster, MRI, newsok, Norman, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OKN-007, OMRF, OUHSC, patients, Rheal, scientist-news, Stephenson Cancer Center, Towner, tumor

  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Before Footer

Equal Opportunity Employer

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Ethics Point
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Ethics Point
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayTop Workplace